NEW YORK ( TheStreet) -- Shares of Cynosure (Nasdaq: CYNO) were gapping up Tuesday morning with an open price 11.2% higher than Monday's closing price. The stock closed at $20.67 Monday and opened today's trading at $22.99. The average volume for Cynosure has been 76,200 shares per day over the past 30 days. Cynosure has a market cap of $209 million and is part of the health care sector and health services industry. Shares are up 84.2% year to date as of the close of trading on Monday. Cynosure, Inc. develops, manufactures, and markets aesthetic treatment systems to the dermatology, plastic surgery, and general medical markets. TheStreet Ratings rates Cynosure as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full Cynosure Ratings Report. Get more investment ideas from our investment research center.